Who We Are

Dilated Cardiomyopathy Overview.
(1993)

Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Hershberger RE, Jordan E

Implementing Precision Medicine for Dilated Cardiomyopathy: Insights from The DCM Consortium.
(2024 Nov 26)
medRxiv
Jordan E, Ni H, Parker P, Kinnamon DD, Owens A, Lowes B, Shenoy C, Martin CM, Judge DP, Fishbein DP, Stoller D, Minami E, Kransdorf E, Smart F, Haas GJ, Huggins GS, Ewald GA, Diamond J, Wilcox JE, Jimenez J, Wang J, Tallaj J, Drazner MH, Hofmeyer M, Wheeler MT, Pinzon OW, Shah P, Gottlieb SS, Katz S, Shore S, Tang WHW, Hershberger RE, DCM Precision Medicine study of the DCM Consortium

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure Trial.
(2024 Dec)
JACC Heart Fail 12(12): 2110-2112
Sears SF, Jordan E, Lindenfeld J, Abraham WT, Weaver FA, Zannad F, Rogers T, Yared F, Wilks SJ, Zile MR

Harm reduction-focused behavioral activation for people who inject drugs: Mixed methods outcomes from a pilot open trial.
(2024 Dec)
J Subst Use Addict Treat 167(): 209490
Paquette C, Vierling A, Kane L, Abrego PL, Benson K, Jordan E, Baucom D, Zule W, Daughters S

ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel: Reappraisal of Genes associated with Hypertrophic Cardiomyopathy.
(2024 Jul 31)
medRxiv
Hespe S, Waddell A, Asatryan B, Owens E, Thaxton C, Adduru ML, Anderson K, Brown EE, Hoffman-Andrews L, Jordan E, Josephs K, Mayers M, Peters S, Stafford F, Bagnall RD, Bronicki L, Callewaert B, Chahal CAA, James CA, Jarinova O, Landstrom AP, McNally EM, Murray B, Muiño-Mosquera L, Parikh V, Reuter C, Walsh R, Wayburn B, Ware JS, Ingles J